Clinical trial
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With…
NCT00003135 · The University of Texas Health Science Center, Houston, Other · Unknown status
Key facts
| NCT number | NCT00003135 |
|---|---|
| Title | Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer |
| Official title | A Phase I-II Trial of Mild Whole-Body Hyperthermia Combined With Liposomal Doxorubicin/5-Fluorouracil in Patients With Advanced Malignancy |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer |
| Intervention type | Drug, Procedure |
| Interventions | fluorouracil, pegylated liposomal doxorubicin hydrochloride, hyperthermia treatment |
| Enrollment | 34 |
| Start date | Nov 1, 1997 |
| Primary completion | Sep 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 30, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: